Literature DB >> 9805190

Methicillin-resistant Staphylococcus aureus septic arthritis: urgent and emergent.

P A Byrne1, I K Hosein, J Camilleri.   

Abstract

A 71-year-old male rheumatoid patient presented with MRSA septic arthritis. The impact of this organism on musculoskeletal practice is discussed.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9805190     DOI： 10.1007/bf01450904

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  8 in total

Review 1.  Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures.

Authors:  J M Boyce
Journal:  Infect Dis Clin North Am       Date:  1997-06       Impact factor: 5.982

Review 2.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

3.  Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community. Report of a combined Working Party of the British Society for Antimicrobial Chemotherapy and the Hospital Infection Society.

Authors: 
Journal:  J Hosp Infect       Date:  1995-09       Impact factor: 3.926

Review 4.  Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals.

Authors:  J M Boyce; M M Jackson; G Pugliese; M D Batt; D Fleming; J S Garner; A I Hartstein; C A Kauffman; M Simmons; R Weinstein
Journal:  Infect Control Hosp Epidemiol       Date:  1994-02       Impact factor: 3.254

Review 5.  Bacterial arthritis.

Authors:  D L Goldenberg; J I Reed
Journal:  N Engl J Med       Date:  1985-03-21       Impact factor: 91.245

Review 6.  Molecular aspects of methicillin resistance in Staphylococcus aureus.

Authors:  H de Lencastre; B L de Jonge; P R Matthews; A Tomasz
Journal:  J Antimicrob Chemother       Date:  1994-01       Impact factor: 5.790

Review 7.  Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.

Authors:  M E Mulligan; K A Murray-Leisure; B S Ribner; H C Standiford; J F John; J A Korvick; C A Kauffman; V L Yu
Journal:  Am J Med       Date:  1993-03       Impact factor: 4.965

8.  Polyarticular septic arthritis.

Authors:  J H Epstein; B Zimmermann; G Ho
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666
  8 in total
  2 in total

1.  Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment.

Authors:  Jon-David Schwalm; Philippe El-Helou; Christine H Lee
Journal:  Can J Infect Dis       Date:  2004-03

2.  High Prevalence of Methicillin-Resistant Staphylococcus aureus among Patients with Septic Arthritis Caused by Staphylococcus aureus.

Authors:  Wei-Ting Lin; Chung-Da Wu; Shun-Chien Cheng; Chong-Chi Chiu; Chi-Chou Tseng; Huan-Tee Chan; Po-Yih Chen; Chien-Ming Chao
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.